Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651]
- RabMAb
- Recombinant
- KO Validated
- Advanced Validation
- What is this?
0
(1 Review)
|
(12 Publications)
Rabbit Recombinant Monoclonal KDM5A / Jarid1A / RBBP2 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), ChIC/CUT&RUN-seq and reacts with Mouse, Human samples. Cited in 12 publications.
View Alternative Names
JARID1A, RBBP2, RBP2, KDM5A, Lysine-specific demethylase 5A, Histone demethylase JARID1A, Jumonji/ARID domain-containing protein 1A, Retinoblastoma-binding protein 2, [histone H3]-trimethyl-L-lysine(4) demethylase 5A, RBBP-2
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (AB194286)
Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling KDM5A / Jarid1A / RBBP2 with ab194286 at 1/2000 dilution followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing nuclear staining on HeLa cell line. The nuclear counter stain is DAPI (blue).
Tubulin is detected with Anti-alpha Tubulin mouse MAb (ab7291) at 1/1000 dilution followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) (ab150120) secondary antibody at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab194286 at 1/2000 dilution followed by Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) (ab150120) secondary at 1/1000 dilution.
-ve control 2 : Anti-alpha Tubulin mouse MAb (ab7291) at 1/1000 dilution followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary at 1/1000 dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (AB194286)
KDM5A / Jarid1A / RBBP2 was immunoprecipitated from 1mg of HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate with ab194286 at 1/100 dilution. Western blot was performed from the immunoprecipitate using ab194286 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : HeLa whole cell lysate 10ug (Input).
Lane 2 : ab194286 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab194286 in HeLa whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 5 seconds.
All lanes:
Immunoprecipitation - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (ab194286)
Predicted band size: 192 kDa
false
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (AB194286)
Intracellular Flow Cytometry analysis of NIH/3T3 (mouse embryo) cells labelling KDM5A / Jarid1A / RBBP2 (red) with purified ab194286 at dilution of 1/1500. The secondary antibody used was Alexa Fluorr® 488 goat-anti-rabbit IgG (1/2000). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Isotype control antibody used was Rabbit Monoclonal IgG (black). The blue line shows cells without incubation with primary antibody and secondary antibody.
- IP
Lab
Immunoprecipitation - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (AB194286)
KDM5A / Jarid1A / RBBP2 was immunoprecipitated from 0.35 mg NIH/3T3 (mouse embryonic fibroblast) whole cell lysate with ab194286 at 1/30 dilution (2µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab194286 at 1/1000 dilution.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
This blot was developed using a high-sensitivity ECL substrate, allowing for the detection of proteins in the mid-femtogram range.
All lanes:
Immunoprecipitation - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (ab194286) at 1/30 dilution
Lane 1:
3T3-L1 (mouse embryonic fibroblast) transfected with scrambled siRNA control whole cell lysate at 7 µg
Lane 2:
3T3-L1 transfected with scrambled siRNA control whole cell lysate
Lane 3:
Rabbit monoclonal IgG (<a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a>) instead of ab194286 in 3T3-L1 transfected with scrambled siRNA control lysate
Lane 4:
3T3-L1 transfected with siRNA specifically targeting KDM5A whole cell lysate at 7 µg
Lane 5:
3T3-L1 transfected with siRNA specifically targeting KDM5A whole cell lysate
Lane 6:
Rabbit monoclonal IgG (<a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a>) instead of ab194286 in 3T3-L1 transfected with siRNA specifically targeting KDM5A lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 200 kDa
true
Exposure time: 180s
- WB
Lab
Western blot - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (AB194286)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : KDM5A knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lane 4 : HEK293 whole cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab194286 observed at 240 kDa. Red - loading control, ab18058, observed at 130 kDa.
ab194286 was shown to specifically recognize KDM5A in wild-type HAP1 cells along with additional cross-reactive bands. No band was observed when KDM5A knockout samples were examined. Wild-type and KDM5A knockout samples were subjected to SDS-PAGE. ab194286 and ab18058 (Mouse anti Vinculin loading control) were incubated overnight at 4°C at 1/2500 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (ab194286)
Predicted band size: 192 kDa
false
- WB
Supplier Data
Western blot - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (AB194286)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (ab194286) at 1/5000 dilution
Lane 1:
LLC (Mouse lung carcinoma) whole cell lysate at 20 µg
Lane 2:
Mouse testis lysate at 20 µg
Lane 3:
HEK-293 (Human epithelial cells from embryonic kidney) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 192 kDa
Observed band size: 192 kDa
false
Exposure time: 30s
- WB
Supplier Data
Western blot - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (AB194286)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (ab194286) at 1/5000 dilution
All lanes:
HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 161 kDa,192 kDa,22 kDa,40 kDa,43 kDa,46 kDa
Observed band size: 162 kDa,192 kDa,43 kDa,46 kDa
false
Exposure time: 10s
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (AB194286)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 K-562 (human chronic myelogenous leukemia lymphoblast) cells and 5 µg of ab194286 [EPR18651]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (AB194286)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 K-562 (human chronic myelogenous leukemia lymphoblast) cells and 5 µg of ab194286 [EPR18651]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (AB194286)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 K-562 (human chronic myelogenous leukemia lymphoblast) cells and 5 µg of ab194286 [EPR18651]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- WB
Supplier Data
Western blot - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (AB194286)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] (ab194286) at 1/1000 dilution
All lanes:
NIH/3T3 (Mouse embryonic fibroblast cells) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 192 kDa
Observed band size: 192 kDa
false
Exposure time: 10s
Related conjugates and formulations (1)
-
Anti-KDM5A / Jarid1A / RBBP2 antibody [EPR18651] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
CNS neuroscience & therapeutics 30:e14830 PubMed39046182
2024
Applications
Unspecified application
Species
Unspecified reactive species
Environmental toxicology 39:341-356 PubMed37713600
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 9:929030 PubMed35845066
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology research 10:1028-1038 PubMed35726891
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell communication and signaling 16:579-599 PubMed35581421
2022
Applications
Unspecified application
Species
Unspecified reactive species
Regenerative therapy 20:95-106 PubMed35509266
2022
Applications
Unspecified application
Species
Unspecified reactive species
Epigenetics & chromatin 14:39 PubMed34384478
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 19:342 PubMed34372882
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:1536 PubMed33750776
2021
Applications
Unspecified application
Species
Unspecified reactive species
Genes & development 33:1718-1738 PubMed31727771
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com